The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
The American Medical Association is urging the U.S. Department of Health and Human Services not to fire members of an advisory panel that determines what cancer screenings and other preventive health measures insurers must cover.
More than 1 in 10 employed respondents report that their employer offers accommodations for their symptoms, which is an increase of 4 percentage points over 2024.
The American Benefits Council is urging Congress to consider the cost to employers, workers and their families as it proposes changes to the 340B drug pricing program.
Although more than one-third of self-funded employers now cover GLP-1 drugs for weight loss, 31% of this group are considering stopping coverage or are unsure about continuing coverage in the next 12 to 24 months.
The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy or Zepbound. Nevertheless, since 2018, Optum Rx charged the union health plan $4,381,075 for 3,732 claims for uncovered weight-loss drugs, the plaintiffs alleged.
In the meantime, the HHS leadership team will be shorthanded as Kennedy and the administration pursue an ambitious health care agenda that includes an overhaul of vaccine policies.
The rule exceeds the authority of the Consumer Financial Protection Bureau and violates the Fair Credit Reporting Act, Judge Sean Jordan of the U.S. District Court for the Eastern District of Texas ruled.